Friday, 27 September 2013

Yahoo! Finance: Biotechnology Industry News: [video] Mad Money tweets

Yahoo! Finance: Biotechnology Industry News
The latest news on the Biotechnology industry from Yahoo! Finance 
TypePad Has the Tools

Looking for a premiere blogging service? Start your blog today on TypePad.
From our sponsors
[video] Mad Money tweets
Sep 27th 2013, 22:45

[at CNBC] - Nektar fell 24 percent today after it announced its critical trial of a drug for chronic pain missed its primary endpoint. Mad Money viewers ask Jim Cramer their investment questions via Twitter.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment